Supplementary Figure 5: Immunized mice sera reactivity to D25, AM14, motavizumab (Mota) and MPE8 epitopes.
From: Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV

Sera from mice immunized with single-chain variants of RSV F were assessed for binding to immobilized DS-CAV1 or immobilized DS-Cav1 bound by neutralizing antibodies D25, AM14, Motavizumab, and MPE8 to assess site specific responses. Each group included 10 mice. Responses were measured by Octet Biolayer interferometry (BLI).